Want to join the conversation?
$BSX expects the LOTUS valve system to be available in select centers in Europe, with commercial site expansion accelerating as physicians and centers become fully trained. The Lotus system is an investigational device in the US and Japan and is not available for sale in those countries.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.